<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Apheresis was applied in 17 patients with <z:hpo ids='HP_0001908'>hypoplastic anemia</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, <z:hpo ids='HP_0003774'>chronic renal failure</z:hpo> and other diseases sensitized to HLA </plain></SENT>
<SENT sid="1" pm="."><plain>Apheresis was done for removal of anti-HLA antibodies and prevention of nonhemolytic transfusion reactions </plain></SENT>
<SENT sid="2" pm="."><plain>Multiple massive apheresis led to a marked decrease in the antibody level </plain></SENT>
<SENT sid="3" pm="."><plain>After the first or second apheresis with removal of 700.0-2000.0 ml of plasma weekly half of the patients showed increasing titres of lymphocytotoxic antibodies </plain></SENT>
</text></document>